Latest News & Features
Americas
The US Federal Trade Commission and AbbVie both want a federal appeals court to rehear a lawsuit accusing the drug company of quashing competition through sham patent litigation. 18 November 2020
Americas
Patent law experts and pharmaceutical companies have lent their support to Merck Sharp & Dohme in its effort to confirm the patent-eligibility of genus claims at the US Supreme Court. 18 November 2020
Big Pharma
The first woman to act as executive director of the European Medicines Agency (EMA) has officially started in the role. 18 November 2020
Americas
Daiichi Sankyo and AstraZeneca have asked the US District Court for the District of Delaware for a declaration that their breast cancer treatment does not infringe a chemotherapy patent owned by biotechnology company Seagen. 18 November 2020
Americas
The role of the doctrine of equivalents in assessing the value of, and risks associated with, medtech patents is often overlooked. Christopher Bright and Nathan Smith of Morgan Lewis report. 18 November 2020
Big Pharma
In response to the surge of COVID-19 infections worldwide, 18 generic drug makers have pledged to join the effort by the Medicines Patent Pool to accelerate global access to effective COVID-19 treatments via a pool for voluntary product licences. 17 November 2020
Big Pharma
German chemicals company BASF has failed to persuade the UK Intellectual Property Office that an applied-for trademark to cover agricultural chemicals is confusingly similar to its own existing trademark. 17 November 2020
Americas
American healthcare multinational Baxter has accused B.Braun of patent infringement and fraudulent misrepresentation in an on-going dispute over products used to treat acute kidney injury. 16 November 2020
Americas
The US Food and Drug Administration will today announce that it plans to grant a Chinese-owned testing company an exclusive worldwide licence for a US government-owned patent covering a diagnostic test for the rapid detection of COVID-19. 13 November 2020
Big Pharma
The European Commission has approved a fourth contract with pharmaceutical companies Pfizer and BioNTech, following their revelation that they had developed a vaccine that could potentially prevent more than 90% of people from becoming infected by COVID-19. 12 November 2020